SCOPUS 정보 검색 플랫폼

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 5, 2002, Pages 66-70

Optimizing the use of erythropoietic agents - Pharmacokinetic and pharmacodynamic considerations

(1) Macdougall, Iain C a

a KING S COLLEGE HOSPITAL (United Kingdom)

Author keywords

Anaemia; Chronic kidney disease; Darbepoetin alfa; Erythropoietin; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; ISOPROTEIN; LIGAND; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; SIALIC ACID; DRUG DERIVATIVE;

ANEMIA; ARTICLE; BINDING AFFINITY; BONE MARROW; CLINICAL TRIAL; CONSENSUS SEQUENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG USE; ERYTHROPOIESIS; HORMONE RECEPTOR INTERACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY METABOLISM; LICENCE; LIVER METABOLISM; METABOLIC CLEARANCE RATE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; BLOOD; CHRONIC KIDNEY FAILURE; KIDNEY; LIVER; METABOLISM; PATHOPHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION;

ANEMIA; BONE MARROW; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LIVER; METABOLIC CLEARANCE RATE; TISSUE DISTRIBUTION;

EID: 0036316443 PISSN: 09310509 EISSN: None Source Type: Journal
DOI: 10.1093/ndt/17.suppl_5.66 Document Type: Article

Times cited : (102)

References (34)

1
- 0023248840
- Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells
- (1987) Biochemistry , vol.26 , pp. 2633-2638
- Davis, J.M.¹ Arakawa, T.² Strickland, T.W.³ Yphantis, D.A.⁴

2
- 0023743771
- Site-specific glycosylation of human recombinant erythropoietin: Analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry
- (1988) Bioehemistry , vol.27 , pp. 8618-8626
- Sasaki, H.¹ Ochi, N.² Dell, A.³ Fukuda, M.⁴

3
- 0000212930
- The role of carbohydrate on the biological activity of erythropoietin
- (1993) Glycoconjugate J , vol.10 , pp. 263
- Egrie, J.C.¹ Grant, J.R.² Gillies, D.K.³ Aoki, K.H.⁴ Strickland, T.W.⁵

4
- 0025977812
- Clinical pharmacokinetics of epoetin recombinant human erythropoietin
- (1991) Clin. Pharmacokinet , vol.20 , pp. 99-113
- Macdougall, I.C.¹ Roberts, D.E.² Coles, G.A.³ Williams, J.D.⁴

5
- 0024562079
- The in vivo metabolism of recombinant human erythropoictin in the rat
- (1989) Blood , vol.73 , pp. 90-99
- Spivak, J.L.¹ Hogans, B.B.²

6
- 0023893906
- Pharmacokinetics of erythropoietin in intact and anephric dogs
- (1988) J. Lab. Clin. Med , vol.111 , pp. 669-676
- Fu, J.-S.¹ Lertora, J.J.L.² Brookins, J.³ Rice, J.C.⁴ Fisher, J.W.⁵

7
- 0021466890
- Metaqabolism of pure human erythropoietin in the rat
- (1984) Am. J. Physiol , vol.247
- Emmanouel, D.S.¹ Goldwasser, E.² Katz, A.I.³

8
- 0024402888
- Single-dose pharmacokinetics of recombinant human erythropoictin in patients with various degrees of renal failure
- (1989) Nephrol. Dial. Transplant , vol.4 , pp. 345-349
- Kindler, J.¹ Eckardt, K.-U.² Ehmer, B.³

9
- 0009772464
- Pharmacokinetics of recombinant erythropoietin in normal and uraernic rats
- (1987) Nephrol. Dial. Transplant , vol.2 , pp. 389
- Scigalla, P.¹ Hoelk, G.² Pahlke, W.³

10
- 0022242694
- Erythropoietin kinetics in normal and uremic sheep
- (1985) J. Lab. Clin. Med , vol.105 , pp. 659-663
- Mladenovic, J.¹ Eschbach, J.W.² Koup, J.R.³ Garcia, J.F.⁴ Adamson, J.W.⁵

11
- 0015451255
- Metabolism of erythropoietin by isolated perfused livers of dogs treated with SKF 525-A
- (1972) Am. J. Physiol , vol.223 , pp. 1345-1348
- Roh, B.L.¹ Paulo, G.² Fisher, J.W.³

12
- 0019469108
- Metabolic studies on erythropoietin (Ep): 11. The role of liver and kidney in the metabolism of Ep
- (1981) Exp. Haematol , vol.9 , pp. 796-803
- Dinkelaar, R.B.¹ Engels, E.Y.² Hart, A.A.M.³

13
- 0024823870
- Erythropoietin metabolism in the isolated perfused rat liver
- (1989) Contrib. Nephrol , vol.76 , pp. 90-97
- Nielsen, O.J.¹ Egljord, M.² Hirth, P.³

14
- 0009769474
- Role of liver in the inactivation of erythropoietin
- (1963) Nature , vol.200 , pp. 899-900
- Fischer, S.¹ Roheim, P.S.²

15
- 0014368267
- The role of the liver and surgical stress
- (1968) Surg. Forum , vol.19 , pp. 348-349
- Kukral, J.¹ Carney, A.I.² Ebroon, E.³

16
- 0030299929
- 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep
- (1996) J. Pharmacol. Exp. Ther , vol.279 , pp. 1205-1210
- Widness, J.A.¹ Veng-Pedersen, P.² Schmidt, R.L.³ Lowe, L.S.⁴ Kisthard, J.A.⁵ Peters, C.⁶

17
- 0002261532
- Peptidases involved in the metabolism of bioactive peptides
- Henriksen JH, ed. CRC Press, Boston
- (1981) Degradation of Bioactive Substances: Physiology and Pathophysiology , pp. 47-80
- Kenny, A.J.¹ Hooper, N.M.²

18
- 0009794222
- Receptor-mediated endocytosis and degradation of polypeptide hormones, growth factors, and neuropeptides
- Henriksen JH, ed. CRC Press, Boston
- (1991) Degradation of Bioactive Substances: Physiology and Pathophysiology , pp. 81-112
- Garnmeltoft, S.¹

19
- 0026527895
- Pharmacokinetics and distribution of recombinant erythropoietin in rats
- (1992) Drug Res , vol.42 , pp. 174-178
- Kinoshita, H.¹ Ohishi, N.² Kato, M.³ Tokltra, S.⁴ Okazaki, A.⁵

20
- 0001026469
- Effect of erythroid hyperplasia on utilization of erythropoietin
- (1965) Nature Lond , vol.206 , pp. 726-727
- Naets, J.P.¹ Wittek, M.²

21
- 0014012879
- Influence of the erythroid activity of the bone marrow on the plasma disappearance of injected erythropoictin in dogs
- 1209
- (1966) Nature Lond , pp. 1140-1141
- Bozzini, C.E.¹

22
- 0026089094
- Erythropoictin life span in rats with hypoplastic and hyperplastic bone marrows
- (1991) Am. J. Hematol , vol.36 , pp. 105-110
- Piroso, E.¹ Erslev, A.J.² Flaharty, K.K.³ Caro, J.⁴

23
- 0034949634
- Development and characterization of novel erythropoiesis stimulating protein (NESP)
- (2001) Nephrol. Dial. Transplant , vol.16 , Issue.SUPPL. 3 , pp. 3-13
- Egrie, J.C.¹ Browne, J.K.²

24
- 0032737391
- Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients
- (1999) J. Am. Soc. Nephrol , vol.10 , pp. 2392-2395
- Macdougall, I.C.¹ Gray, S.J.² Elston, O.³ Breen, C.⁴ Jenkins, B.⁵ Browne, J.⁶ Egrie, J.⁷

25
- 0009791315
- Data on file. Amgen Inc

26
- 0025653603
- Daily self-administered subcutaneous erythropoietin: Benefits in haemodialysis patients
- (1990) Contrib. Nephrol , vol.82 , pp. 49-54
- Granolleras, C.¹ Branger, B.² Deschodt, G.³ Shaldon, S.⁴ Nornnast-Daniel, B.⁵ Pollok, M.⁶

27
- 0025727829
- Correction of anaemia in patients on continuous ambulatory peritoneal dialysis with subcutaneous recombinant erythropoietin twice a week: A long-term study
- (1991) Clin. Nephrol , vol.35 , pp. 207-212
- Cheng, I.K.P.¹ Cy, C.² Chan, M.K.³ Yu, L.⁴ Fang, G.X.⁵ Wei, D.⁶

28
- 0033652431
- The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: Results from a randomized controlled multicentre trial
- (2000) Nephrol. Dial. Transplant , vol.15 , pp. 2014-2019
- Weiss, L.G.¹ Clyne, N.² Fihlho, J.D.³ Frisenette-Fich, C.⁴ Kurkus, J.⁵ Svensson, B.⁶

29
- 0000206617
- Novel Erythropoiesis Stimulating Protein (NESP) for the treatment of renal anaernia
- on behalf of the UK NESP Study Group
- (1998) J. Am. Soc. Nephrol , vol.9
- Macdougall, I.C.¹

30
- 0000203171
- Novel crythropoiesis stimulating protein (NESP) maintains hemoglobin in ESRD patients when administered once-weekly or once every other week
- on behalf of the European Australian NESP 970200 Study Group
- (1999) J. Am. Soc. Nephrol , vol.10
- Vanrenterghern, Y.¹ Barany, P.² Mann, J.³

31
- 0034919301
- Novel erythropoiesis stimulating protein for treatment of anaemia in chronic renal insufficiency
- (2001) Kidney Int , vol.60 , pp. 741-747
- Locatelli, F.¹ Olivares, J.² Walker, R.³

32
- 0001075199
- Novel erythropoiesis stimulating protein (NESP) administered once every 3 weeks by the intravenous or subcutaneous route maintains hemoglobin (Hb) in dialysis patients
- and the European/Australian NESP 2000 0144 Study Group
- (2001) J. Am. Soc. Nephrol , vol.12
- Vanrenterghern, Y.¹ Jadoul, M.² Foret, M.³ Walker, R.⁴

33
- 0032572918
- Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis
- Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients
- (1998) N. Engl. J. Med , vol.339 , pp. 578-583
- Kaufman, J.S.¹ Reda, D.J.² Fye, C.L.³

34
- 0027217873
- Optimizing epoetin therapy in end-stage renal disease: The case for subcutaneous administration
- (1993) Am. J. Kidney Dis , vol.22 , pp. 13-22
- Besarab, A.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.